During Thursday’s Afternoon trade, Shares of Palatin Technologies Inc. (NYSEMKT:PTN), gained 7.22% to $1.04.
Palatin Technologies is a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with noteworthy unmet medical needs and commercial potential. Palatin’s lead product under development is bremelanotide for the treatment of female sexual dysfunction (FSD).
The approval of flibanserin (under development by Sprout Pharmaceuticals) recently by the U.S. Food and Drug Administration (FDA) marks a long-awaited milestone in healthcare for women. The FDA’s approval of flibanserin validates that there is an important need for women living with hypoactive sexual desire disorder, or HSDD, to have an approved treatment option. Palatin applauds the FDA’s positive determination, which supports FDA’s previous statements that HSDD is an unmet medical need requiring a safe treatment option for women with HSDD.
Palatin Technologies, Inc., a biopharmaceutical company, develops peptide therapeutics for the treatment of diseases. The company’s clinical development product is Bremelanotide, a peptide melanocortin receptor agonist that has accomplished Phase 2B clinical trial for the treatment of female sexual dysfunction (FSD).
Shares of Alibaba Group Holding Limited (NYSE:BABA), declined -2.37% to $71.39, during its current trading session.
Aliyun, Alibaba Group’s (BABA) cloud computing arm, declared that it will establish a new cloud data center in Singapore. Its headquarters for overseas business will also be based out of Singapore to drive Aliyun’s overseas expansion plan. Planned for an early September launch, the Singapore facility will be the seventh globally.
The new cloud data center leverages on Alibaba Group’s recent US$1 billion investment for cloud computing, and will enable more businesses to benefit from secure and reliable Aliyun-powered cloud services while riding on record foreign direct investment flows in Southeast Asia.
Alibaba Group Holding Limited, through its auxiliaries, operates as an online and mobile commerce company in the People’s Republic of China and internationally. It operates Taobao Marketplace, an online shopping destination; Tmall, a third-party platform for brands and retailers; Juhuasuan, a group buying marketplace; Alibaba.com, an online wholesale marketplace; Alitrip, an online travel booking platform; 1688.com, an online wholesale marketplace; and AliExpress, a consumer marketplace.
Finally, Oracle Corporation (NYSE:ORCL), lost -1.29%, and is now trading at $39.02.
Oracle Corporation declared that it has signed a contract to acquire Maxymiser, a leading provider of cloud-based software that enables marketers to test, target and personalize what a customer sees on a Web page or mobile app, substantially increasing engagement and revenue. Maxymiser optimizes over 20 billion customer experiences per month for brands such as Allianz, HSBC, Lufthansa, Tommy Hilfiger and Wyndham.
Oracle Marketing Cloud is already the fastest growing software platform for modern marketers in the world. The addition of Maxymiser to Oracle Marketing Cloud will strengthen the most comprehensive solution to manage marketing programs across all digital channels and across the customer lifecycle.
Oracle Corporation develops, manufactures, markets, sells, hosts, and supports database and middleware software, application software, cloud infrastructure, hardware systems, and related services worldwide.
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties, which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified with such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.